Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study
- PMID: 16443733
- PMCID: PMC1860322
- DOI: 10.1136/jcp.2005.028431
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study
Abstract
Background: Cutaneous melanoma spreads preferentially through the lymphatic route and sentinel lymph node (SLN) status is regarded as the most important predictor of survival.
Aims: To evaluate whether tumour lymphangiogenesis and the expression of vascular endothelial growth factor C (VEGF-C) is related to the risk of SLN metastasis and to clinical outcome in a case-control series of patients with melanoma.
Methods: Forty five invasive melanoma specimens (15 cases and 30 matched controls) were investigated by immunostaining for the lymphatic endothelial marker D2-40 and for VEGF-C. Lymphangiogenesis was measured using computer assisted morphometric analysis.
Results: Peritumorous lymphatic vessels were more numerous, had larger average size, and greater relative area than intratumorous lymphatics. The number and area of peritumorous and intratumorous lymphatics was significantly higher in melanomas associated with SLN metastasis than in non-metastatic melanomas. No significant difference in VEGF-C expression by neoplastic cells was shown between metastatic and non-metastatic melanomas. Using logistic regression analysis, intratumorous lymphatic vessel (LV) area was the most significant predictor of SLN metastasis (p = 0.04). Using multivariate analysis, peritumorous LV density was an independent variable affecting overall survival, whereas the intratumorous LV area approached significance (p = 0.07).
Conclusions: This study provides evidence that the presence of high peritumorous and intratumorous lymphatic microvessel density is associated with SLN metastasis and shorter survival. The intratumorous lymphatic vessel area is the most significant factor predicting SLN metastasis. The tumour associated lymphatic network constitutes a potential criterion in the selection of high risk patients for complementary treatment and a new target for antimelanoma therapeutic strategies.
Similar articles
-
Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462. Arch Dermatol. 2008. PMID: 18427039
-
Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.Int J Surg Pathol. 2015 Dec;23(8):629-37. doi: 10.1177/1066896915583694. Epub 2015 Apr 24. Int J Surg Pathol. 2015. PMID: 25911567
-
The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.J Clin Pathol. 2005 Jul;58(7):715-21. doi: 10.1136/jcp.2004.020123. J Clin Pathol. 2005. PMID: 15976338 Free PMC article.
-
Tumor lymphangiogenesis and melanoma metastasis.J Cell Physiol. 2008 Aug;216(2):347-54. doi: 10.1002/jcp.21494. J Cell Physiol. 2008. PMID: 18481261 Review.
-
Lymphangiogenesis and Anti-lymphangiogenesis in Cutaneous Melanoma.Anticancer Res. 2016 Sep;36(9):4427-35. doi: 10.21873/anticanres.10986. Anticancer Res. 2016. PMID: 27630278 Review.
Cited by
-
Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?Pathol Oncol Res. 2012 Apr;18(2):253-62. doi: 10.1007/s12253-011-9436-1. Epub 2011 Jul 23. Pathol Oncol Res. 2012. PMID: 21785902
-
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma.Clin Cancer Res. 2012 Jan 1;18(1):229-37. doi: 10.1158/1078-0432.CCR-11-0490. Epub 2011 Nov 17. Clin Cancer Res. 2012. PMID: 22096024 Free PMC article. Clinical Trial.
-
Significantly high lymphatic vessel density in cutaneous metastasizing melanoma.Hippokratia. 2015 Jul-Sep;19(3):210-5. Hippokratia. 2015. PMID: 27418778 Free PMC article.
-
Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.World J Gastroenterol. 2007 Mar 28;13(12):1794-7; discussion 1797-8. doi: 10.3748/wjg.v13.i12.1794. World J Gastroenterol. 2007. PMID: 17465468 Free PMC article.
-
In Vivo Longitudinal Tracking of Lymphangiogenesis and Angiogenesis in Cutaneous Melanoma Mouse Model Using Multifunctional Optical Coherence Tomography.JID Innov. 2021 Mar 18;1(2):100010. doi: 10.1016/j.xjidi.2021.100010. eCollection 2021 Jun. JID Innov. 2021. PMID: 34909714 Free PMC article.
References
-
- Rigel D S. Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment. CA Cancer J Clin 199646195–198. - PubMed
-
- WHO WHO declares lymphatic mapping to be the standard of care for melanoma. Oncology 199913288
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical